Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for AlertsDetails
Title
Grant Type
Focus Area
Country
Application Due Date
BCMA-Directed Bispecific Antibody Treatment in Multiple Myeloma
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Oncology Japan
Research on MBL producing Enterobacterales and/or Stenotrophomonas maltophilia
Release Date:
Review Process: Pfizer Internal
Research Hospital Austria, Brazil, China, France, Germany, Greece, India, Italy, Mexico, Saudi Arabia, Spain, Taiwan, Turkey, United Kingdom
Increase Awareness & Understanding of Emerging Hemophilia Treatment Options (Global excluding United States)
Release Date:
Review Process: Pfizer Internal
Education Rare Disease All
Optimal management of patients with prostate cancer receiving androgen deprivation therapy (ADT)
Release Date:
Partner: Sumitomo Pharma
Review Process: Pfizer Internal
Education Oncology USA
Title
Grant Type
Focus Area
Country
Application Due Date
Rheumatology Education Healthcare Disparities
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Promotion of the Appropriate Diagnosis and Treatment of Overactive Bladder or Neurogenic Bladder
Release Date:
Review Process: Pfizer Internal
Education Internal Medicine Japan
Improving Knowledge and Capability to Communicate Information on the Latest Hemophilia Treatments
Release Date:
Review Process: Pfizer Internal
Education Rare Disease Japan
Equity in Access to Cancer Cachexia Clinical Trials
Release Date:
Review Process: Pfizer Internal
Quality Improvement Internal Medicine All
Infectious Disease Fellowship
Release Date:
Review Process: Expert Review Panel
Fellowship Hospital India
Inflammatory Bowel Disease (Europe, Canada, Australia, New Zealand, Japan, Israel and Turkey)
Release Date:
Review Process: Expert Review Panel
Fellowship Inflammation & Immunology All
Raising Awareness and Promoting Timely Diagnosis of TTR Amyloidosis
Release Date:
Partner: Mayo Clinic
Review Process: Expert Review Panel
Translation: Arabic (link)
Translation: French (link)
Translation: Mandarin (link)
Translation: Spanish (link)
Quality Improvement Rare Disease All
2022 Growth Hormone Research
Release Date:
Review Process: Pfizer Internal
Research Rare Disease All
Meta-analysis of COVID-19 Vaccine Hesitancy Behavioral & Social Science Research
Release Date:
Review Process: Pfizer Internal
Research Vaccines USA
New & Emerging Therapies for Atopic Dermatitis for Dermatologists, Allergists, and Advanced Practice Providers
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Addressing the Needs of Patients with Mental Health Issues and Inflammatory Bowel Diseases
Release Date:
Review Process: Pfizer Internal
Quality Improvement Inflammation & Immunology Canada
Improving the Care of Patients with Disorders of Impaired Growth
Release Date:
Partner: ICOSEP
Review Process: Expert Review Panel
Quality Improvement Rare Disease All